Avarga Limited (SGX:X5N)

Market Cap	244.34M
Revenue (ttm)	1.59B
Net Income (ttm)	3.81M
Shares Out	90.83M
EPS (ttm)	0.04
PE Ratio	64.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,400
Average Volume	8,450
Open	2.740
Previous Close	2.740
Day's Range	2.690 - 2.760
52-Week Range	1.850 - 2.890
Beta	0.77
RSI	43.24
Earnings Date	Aug 12, 2025

About Checkpoint Therapeutics

Avarga Limited, an investment holding company, manufactures and sells paper products in Canada, the United States, Malaysia, Singapore, Sri Lanka, and internationally. It operates in three segments: Paper Mill Division, Wholesale Distribution of Building Products, and Others. The company manufactures and sells industrial-grade paper products from recycled wastepaper, such as testliner, corrugating medium, chip board, and core board that are primarily used to manufacture corrugated carton boxes and other finished paper products; and provides man...

• Industry: Paper and Allied Products
• Founded: 1967
• Employees: 593
• Stock Exchange: Singapore Exchange
• Ticker Symbol: X5N

Financial Performance

In 2024, Avarga's revenue was 1.62 billion, a decrease of -4.26% compared to the previous year's 1.69 billion. Earnings were 23.56 million, an increase of 115.60%.